يعرض 1 - 20 نتائج من 47 نتيجة بحث عن '"Kelvin C. de Andrade"', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المصدر: Genome Medicine, Vol 10, Iss 1, Pp 1-9 (2018)

    وصف الملف: electronic resource

  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    المصدر: Cellular and Molecular Neurobiology. 41:1285-1297

  16. 16
  17. 17
  18. 18
  19. 19

    المصدر: JNCI Cancer Spectr

  20. 20

    المساهمون: Division of Cancer Epidemiology and Genetics [Bethesda, MD, États-Unis], National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH)-National Institutes of Health [Bethesda] (NIH), Frederick National Laboratory for Cancer Research (FNLCR), National Institutes of Health [Bethesda] (NIH), University of Wisconsin - Milwaukee, University of KwaZulu-Natal (UKZN), Institut de transplantation urologie-néphrologie (ITUN), Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), Centre de Recherche en Transplantation et Immunologie (U1064 Inserm - CRTI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Department of Health Sciences Research [Mayo Clinic] (HSR), Mayo Clinic, Yale School of Public Health (YSPH), American Cancer Society [Atlanta, GA, USA], Baylor University, Fred Hutchinson Cancer Research Center [Seattle] (FHCRC), Massachusetts Institute of Technology (MIT), This work was supported by the intramural research programof the Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI). The Center for International Blood and Marrow Transplant Research (CIBMTR) is supported primarily by Public Health Service Grant/Cooperative Agreement 5U24CA076518 from the NCI, the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID), Grant/Cooperative Agreement 4U10HL069294 from the NHLBI and the NCI, contract HHSH250201200018C with the Health Resources and Services Administration (HRSA/ DHHS), and two grants, N00014-17-1-2388 and N0014-17-1-2850, from the Office of Naval Research. The Mayo Clinic Case-Control Study of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (MAYO) study is funded through grants R01 CA92153 and P50 CA97274. TheNCI Surveillance, Epidemiology, and End Results Non-Hodgkin Lymphoma Case-Control Study (NCI-SEER) study is funded by the Intramural Research Programof theNCI,National Institutes of Health (NIH), and Public Health Service (N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, and N02-PC- 71105). The Population-based Case-Control Study in Connecticut Women (YALE) is funded through the NCI (CA62006 and CA165923). This project has also been funded in part with federal funds from the Frederick National Laboratory for Cancer Research, under Contract No. HHSN261200800001E., University of KwaZulu-Natal [Durban, Afrique du Sud] (UKZN), Le Bihan, Sylvie

    المصدر: American Journal of Human Genetics
    American Journal of Human Genetics, Elsevier (Cell Press), 2020, 106 (2), pp.264-271. ⟨10.1016/j.ajhg.2020.01.004⟩
    Am J Hum Genet
    American Journal of Human Genetics, 2020, 106 (2), pp.264-271. ⟨10.1016/j.ajhg.2020.01.004⟩